These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26208521)

  • 1. Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective.
    Lorenzi AT; Syrjänen KJ; Longatto-Filho A
    Virol J; 2015 Jul; 12():112. PubMed ID: 26208521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of human papillomavirus DNA screening in the world: 15 years of experience.
    Castle PE; de Sanjosé S; Qiao YL; Belinson JL; Lazcano-Ponce E; Kinney W
    Vaccine; 2012 Nov; 30 Suppl 5():F117-22. PubMed ID: 23199954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening by cytology and human papillomavirus testing during pregnancy in French women with poor adhesion to regular cervical screening.
    Brun-Micaleff E; Coffy A; Rey V; Didelot MN; Combecal J; Doutre S; Daurès JP; Segondy M; Boulle N
    J Med Virol; 2014 Mar; 86(3):536-45. PubMed ID: 24114972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of increasing cervical cancer screening coverage in the Middle East: An example from Lebanon.
    Sharma M; Seoud M; Kim JJ
    Vaccine; 2017 Jan; 35(4):564-569. PubMed ID: 28017434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the clinical performance of high-risk human papillomavirus testing for primary screening: a retrospective review of the Southern California Permanente Medical Group experience.
    Lonky NM; Mahdavi A; Wolde-Tsadik G; Bajamundi K; Felix JC
    J Low Genit Tract Dis; 2010 Jul; 14(3):200-5. PubMed ID: 20592555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rationale for implementation of HPV testing in routine cervical screening in Romania.
    Iancu LS; Ursu RG
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
    [No Abstract]   [Full Text] [Related]  

  • 9. Human papillomavirus testing for primary cervical cancer screening.
    Grce M; Davies P
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cervical cancer screening].
    Aoki D; Saito E; Tominaga E
    Gan To Kagaku Ryoho; 2012 Jan; 39(1):23-6. PubMed ID: 22241349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV testing and vaccination in Europe.
    Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
    J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer control in Latin America: A call to action.
    Bychkovsky BL; Ferreyra ME; Strasser-Weippl K; Herold CI; de Lima Lopes G; Dizon DS; Schmeler KM; Del Carmen M; Randall TC; Nogueira-Rodrigues A; de Carvalho Calabrich AF; St Louis J; Vail CM; Goss PE
    Cancer; 2016 Feb; 122(4):502-14. PubMed ID: 26670695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
    Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
    J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
    J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chapter 10: New dimensions in cervical cancer screening.
    Cuzick J; Mayrand MH; Ronco G; Snijders P; Wardle J
    Vaccine; 2006 Aug; 24 Suppl 3():S3/90-7. PubMed ID: 16950022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-collection for high-risk HPV detection in Brazilian women using the careHPV™ test.
    Lorenzi AT; Fregnani JH; Possati-Resende JC; Neto CS; Villa LL; Longatto-Filho A
    Gynecol Oncol; 2013 Oct; 131(1):131-4. PubMed ID: 23880151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of low-risk HPV infection for the risk of abnormal cervical cytology/histology in more than 40 000 Danish women.
    Nielsen A; Iftner T; Nørgaard M; Munk C; Junge J; Kjaer SK
    Sex Transm Infect; 2012 Dec; 88(8):627-32. PubMed ID: 22773328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.